NCT00692328 Expectation and Response to Levodopa and Acupuncture in Parkinson's Disease Status COMPLETED Phase NA
NCT00674895 Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD) Status UNKNOWN Phase PHASE1
NCT00674310 A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions Status COMPLETED Phase NA
NCT00673088 A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions Status COMPLETED Phase NA
NCT00669461 Lubiprostone as a Treatment for Constipation in Parkinson's Disease Status TERMINATED Phase NA
NCT00666653 Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease Status COMPLETED Phase PHASE1
NCT00664209 Treating H. Pylori in Parkinson's Patients With Motor Fluctuations Status TERMINATED Phase PHASE3
NCT00656253 Clinical Trial on the Effectiveness of Herbal Medicinal Mixture in Parkinson Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00646204 Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease Status COMPLETED Phase PHASE4
NCT00643890 Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease Status TERMINATED Phase PHASE2
NCT00642928 Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients Status COMPLETED Phase PHASE2
NCT00642889 Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension) Status COMPLETED Phase PHASE3
NCT00642356 Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off Status TERMINATED Phase PHASE4
NCT00640952 Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease Status WITHDRAWN Phase NA
NCT00640159 Selegiline to Zelapar Switch Study in Parkinson Disease Patients Status COMPLETED Phase PHASE4
NCT00632736 An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease Status COMPLETED Phase PHASE3
NCT00627588 Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease Status COMPLETED Phase PHASE1/PHASE2